Unconventional Isoquinoline-Based SERMs Elicit Fulvestrant-Like Transcriptional Programs in ER⁺ Breast Cancer Cells

To improve the understanding of ERα structure-transcriptional relationships, scientists developed a series of chemically unconventional antagonists based on the antiestrogens elacestrant and lasofoxifene.